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Abstract 
 
Resistance to chemotherapy is believed to cause treatment failure of the patient 
cancer. Secang (Caesalpinia sappan L.) has been proven to possess anticancer activity on some 
cancer cell lines. The aimed of this study to develop ethanolic extract of secang wood (EES) 
as chemosensitizing agent through apoptotic induction on breast cancer MCF-7 cells. 
Extraction of secang was done by using maceration with 70 % ethanol. Single and 
combinatorial treatment of EES and doxorubicin on MCF-7 breast cancer cells were analyzed 
by using MTT assay to determine the IC50 value and combination index (CI) to evaluate the 
combinatorial effect. Apoptosis was analyzed with flowcytometry (annexin V).  EES showed a 
dose-dependent cytotoxicity (IC50 value of 37 µg/ml), while combinatorial treatment showed 
that 7 concentrations was found to be synergist with doxorubicin on MCF-7 cells. 
Combinatorial treatment also triggered apoptotic instead of single treatment. Based on this 
result, we conclude that ethanolic extract of secang wood is potential as chemosensitizing 
agent in breast cancer. 
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INTRODUCTION 
 
Doxorubicin is one of the primary 
chemotherapeutic agents for breast cancer 
treatment. Medical report by Rumah Sakit 
Kanker Dharmais stated that in 2007 breast 
cancer shows the highest incidence compared to 
another cancer types (Anonymous, 2009). The 
main problem of clinical systemic 
chemotherapy are its toxicity towards normal 
tissues and suppression of the immune system 
(Wattanapitayakul et al., 2005), and occurrence 
of resistance (Mechetner et al., 1998). 
Resistance to chemotherapy is believed to cause 
treatment failure of the patient. One promising 
approach to solve this problem is the 
application of chemosensitizing agent in cancer 
therapy. 
Potent agent which can be used as 
chemosensitizing agent together with 
doxorubicin are phytochemical substances, 
rendering to the fact that there are huge number 
of substances found in plants that are potential 
against cancer (Gibbs, 2000), such as 
homoisoflavonoid namely brazilin, brazilien, 4-
O-methylsappanol, protosappanin A, and 
caesalpin J  which found in secang wood  (Lim 
et al.,1997). It was suspected to have anticancer 
effect.  Therefore, further study on its potential 
as co-chemotherapeutic agent needs to be 
conducted. 
This study aimed to observe cytotoxic 
effect of ethanolic extract of secang wood 
(EES) single or in combination with 
doxorubicin, analyzed by using MTT assay. 
Combinatorial treatment of EES and 
doxorubicin were applied in order to increase 
the cytotoxicity of doxorubicin on MCF-7 cells, 
allowing the use of lower dose of the 
chemotherapeutic agent giving less toxicity on 
normal tissues. 
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MATERIALS AND METHODS  
 
Extraction 
Secang woods were collected from 
Yogyakarta, Indonesia which then determined 
Department of Pharmaceutical Biology, Faculty 
of Pharmacy UGM. Dried powder was then 
extracted by maceration for 5 days with 70% 
ethanol. Collected filtrate was concentrated 
using rotary evaporator (Heidolph WB2000).  
 
Cell culture 
MCF-7 cells are collection of Cancer 
Chemoprevention Research Center (CCRC), 
Faculty of Pharmacy, Universitas Gadjah Mada, 
Yogyakarta, Indonesia. The cell was a gift from 
Prof. Kawaichi, Nara Institute of Science and 
Technology (NAIST), Japan. Dulbecco’s 
Modified Eagle Medium (DMEM) powder 
(Gibco) containing 10%v/v Fetal Bovine Serum 
(FBS) (Gibco), and 10,000 units/ml Penicillin-
10,000 μg/ml Streptomycin (Gibco) were used 
for culture medium. Cells were prepared using 
0.25% Tripsin EDTA (Gibco). 
 
Cytotoxicity assay  
MTT cytotoxicity assay was used to 
examine the effect of ethanolic extract of 
secang wood on MCF 7 cells, either single or in 
combination with doxorubicin. Cells were 
distributed to 96-well plate (Nunc) with the 
density of 5x10
3
 cells/well and incubated in 
37˚C with 5% CO2 for 24 hours. For the 
cytotoxicity assay of ethanolic extract of secang 
wood, a serial concentration of ethanolic extract 
of secang wood was diluted on DMEM with 
DMSO (Sigma) as co-solvent, to get IC50 value. 
In combinatorial assay, concentration of about 
1/12, 1/8, 1/4, and 3/8 IC50 were used for both 
EES and doxorubicin. After 24 hours 
incubation, 3-[4,5-dimethyl thiazole-2-yl(-2,5- 
diphenyltetrazoliumbromide)] (MTT) (Sigma) 
was added, followed by 4 hours incubation. 
Then 10%v/v SDS in 0.1N HCl (Merck) as 
stopper reagent was added. Plate was then kept 
with protection from light overnight, continued 
with absorbance measurement (λ 595 nm) using 
ELISA reader (Bio-Rad). IC50 value, a 
concentration which inhibits 50% cell 
population, was calculated from linear 
regression of log concentration versus cells 
viability.  
 
Apoptotic Induction 
Cells (5x10
4
 cells/well) were transfered 
to 6-well plate (Iwaki) and incubated for 24 
hours (37°C 5 % CO2 condition). Cells were 
treated by EES, doxorubicin, and their 
combination, and then incubated for 15 hours. 
Then, cells were centrifugated and added by 
100 annexin V-FITC which was diluted in 
binding buffer. Cells were incubated for 15 
minutes and analyzed with flowcytometry λ 
488 nm. 
 
Analysis 
Combinatorial Assay. Combinatorial 
treatment was evaluated by calculating 
Combination Index (CI) value (Reynolds and 
Maurer, 2005), which has the formula as 
follows. 
   
  
   
 
  
   
 
     
       
 
D1 and D2 represent concentrations used in 
combinatorial treatment, while Dx1 and Dx2 are 
single treatment concentration giving the same 
response as D1 and D2, respectively. CI value 
acquired will allow the evaluation of EES’s 
potency in combinatorial treatment with 
doxorubicin on MCF-7 cell lines. Interpretation 
was done based on the classification listed in 
Table I.  
 
 
Table I. Interpretation of CI Values 
CI Interpretation 
< 0.1 
0.1-03 
0.3-0.7 
0.7-0.9 
0.9-1.1 
1.1-1.45 
1.45-3.3 
> 3.3 
Very strong synergistic effect 
Strong synergistic effect  
Synergistic effect 
Moderate synergistic effect 
Nearly additive effect 
Moderate antagonist effect 
Antagonist effect 
Very strong antagonist effect  
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RESULTS AND DISCUSSION  
 
In this study we explored the effect of 
EES single and in combination with 
doxorubicin on cytotoxicity, and apoptotic 
induction of MCF-7 breast cancer cells. Secang 
(Caesalpinia sappan L.) had been proved to 
have cytotoxic and antiproliferative effect 
against several cancer cell lines such as HepG2, 
MDA-MB-231 dan MCF-7, A549 cells (Yen et 
al., 2010). Our study showed that single 
treatment of EES show cytotoxic effect on 
MCF-7 with IC50 37 μg/ml (Fig. 1). According 
to Ueda et al. (2000), IC50 value less than 100 
µg/ml shows that related agent has a potent 
cytotoxicity. Observation of cell morphology 
after treatment was also done, shown in Fig. 2 
and 3. Increasing concentration of EES was 
followed by the increasing number of dead 
cells, quantitatively (Fig. 1).   
Previous study showed that doxorubicin 
showed strong cytotoxic effect on MCF-7 
breast cancer cell lines with IC50 value 400 µM 
(Hermawan et al., 2010). This is due to the 
characteristic of MCF-7 which is resistant to 
doxorubicin by overexpressing anti-apoptotic 
protein Bcl-2 and P-glycoprotein efflux pump 
(Davis et al., 2003). To increase the sensitivity 
of MCF-7 cells towards doxorubicin, we 
combined doxorubicin with EES. 
Our results showed that 7 combinatorial 
concentration EES and doxorubicin gave 
synergistic which had CI under 0.9 (Reynolds 
and Maurer, 2005 (Table II). Combination of 
EES and doxorubicin (18 µg/ml–25 nM) 
showed higher inhibition of proliferation than 
single treatment in MCF-7 cells (Fig. 2(A)). 
Observation of cell morphology after treatment 
was also done, shown in Fig. 2(B-E). This 
result suggested that this combination give 
synergistic effect on MCF-7 cells. This 
synergistic effect is occured due to apoptotic 
induction and/or cell cycle modulation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                               
 
Figure 1. Cytotoxic effect of single treatment EES on MCF-7 cells. Cells were cultured in 96 well 
plate then treated with EES for 24h (A) The effect of EES to the viability of MCF-7 cells; 
(B) cell control; (C) 10 µg/ml; (D) 25 µg/ml; (E) 50 µg/ml; (F) 100 µg/ml. Higher 
concentration of EES caused more change in cells’ morphology (round cells being 
unattached to the well). This phenomenon represents a dose-dependent manner. EES’s 
cytotoxicity was represented as percentage of MCF-7 cells’ viability as the mean + SD of 
three experiments, p <0.05. 
 
 
 
(A) (B) (C) 
(D) (E) (F) 
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Figure 2. Cytotoxic effects of combinatorial treatment EES and doxorubicin on MCF-7 cells. Cells 
were cultured in 96 well plate then treated with EES, Doxorubicin, and the combination  
for 24h  (A) The effect of EES to the viability of MCF-7 cells; (B) cell control; (C) EES 18 
µg/ml; (D) doxorubicin 25 nM; (E) 18 µg/ml-.25nM. Combinatorial concentration of EES 
caused more change in cells’ morphology (rounded and deattached cells) 
 
Table II. CI values of combinational treatment of EES and doxorubicinon MCF-7 cells. 
EES (µg/ml) Doxorubicin (nM) 
25 50 100 200 
4, 5 1,29 1,36 3,70 9,36 
9 1,77 0,90 2,41 7,60 
13,5 1,59 0,98 0,78 0,83 
18 0,29 0,32 0,34 0,74 
 
We next investigated whether the EES 
induced apoptosis on MCF-7 cells. The results 
from cytotoxic assay of EES and doxorubicin 
were parallel with apoptotic assay using 
flowcytometry-annexin V-FITC. Combinatorial 
treatment increased the death cells caused by 
apoptosis (Fig.3). Single treatment of EES 
showed cytotoxic effect and the combination 
with doxorubicin increased cytotoxicity of 
doxorubicin in MCF-7 cells. Single treatment of 
EES did not induce apoptotic, but the 
combination with doxorubicin increased 
apoptosis induction of doxorubicin in MCF-7 
cells. This result indicated that synergist effect 
of EES and doxorubicin was through apoptotic 
induction. 
The increased cytotoxic of doxorubicin 
by EES probably due to up-regulation of p53 
and inhibition of Bcl-2.  Doxorubicin induces 
DNA damage and triggers the apoptotic 
pathway or DNA repair depend on the degree 
of DNA. In the cells with wild type p53 e.g. 
MCF-7 cells, upregulation of p53 could 
increase apoptosis induction or G2/M arrest. 
Previous study mentioned chloroform extract of 
secang induced expression of p53 on 
HNSCC31 cells and HNSCC4 cells (head and 
neck cancer cell line) (Kim et al., 2005). Other 
study mentioned that brazilein as active 
compound of secang induced apoptotic through 
modulated Bcl-2 and survivin in HepG2 cells 
(Zhong et al., 2009).  Our results is similar to 
(A) (B) 
(C) (D) (E) 
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the previous study, but the mechanism need to be explored more details in MCF-7 cells. 
 
 
 
 
 
 
 
 
 
 
 
(E) 
 
 
 
 
 
 
 
 
 
Figure 3. The effect of EES and doxorubicin on MCF-7 cells apoptosis. Cells (5x104) were treated with 
EES, doxorubicin, combination, and then incubated for 15 hours. Viable and dead cells 
were observed with flowcytometry method. (A) control; (B) EES 18 µg/ml; (C) 
doxorubicin 200nM; (D) EES-doxorubicin (18 µg/ml -200nM; (E) Graph represent the 
number of cells each phase. 
 
ACKNOWLEDGEMENT 
 
We acknowledge Cancer 
Chemoprevention Research Center which has 
funded this research. 
 
 
 
 
REFERENCES 
 
Anonymous, 2009, Rumah Sakit Kanker 
Dharmais’ Medical Report; Statistik 
Kanker: 10 Besar Kanker Tersering 
RSKD Rawat Jalan (Kasus Baru) tahun 
2007, available in 
http://www.dharmais.co.id/index.php/can
Khamsita, et al., 2012 
Indones. J. Cancer Chemoprevent., 3(3), 444-449 
 
449 
 
cer-statistic.html, accessed on March 
2010. 
Davis, J.M., Navolonic, P.M., Weinstein, C.R., 
Steelman, L.S., Hu, Konovlepa, M., 
Blagosklonny M.V. and McCubrey, J.A., 
2003, Raf-1 and Bcl-2 Induce Distinct 
dan Commn Pathway That Contribute 
to Cancer Drug Resistance, Clin. Cancer 
Res., 9, 1161-1170. 
Gibbs, J.B., 2000, Anticancer Drug Targets: 
Growth Factor and Growth Factor 
Signaling, J. Clin. Inves., 105(1), 9-13. 
Hermawan, A., Meiyanto, E. and Susidarti, A., 
2010, Hesperidin Meningkatkan Aktivitas 
Sitotoksik Doxorubicin pada Sel MCF-7, 
Indonesian J. of Pharm., 21(1), 8-17. 
Kim, E.C., Hwang, Y.S. and Lee, H.J., 2005, 
Caesalpinia sappan induces cell death by 
increasing the expression of p53 and 
p21WAF1/CIP1 in head and neck cancer 
cells, Am. J. Chin. Med., 33, 405–14. 
Lim, D.K., Choi, U. and Shin, D.H., 1997, 
Antioxidative activity of some solvent 
extract from Caesalpinia sappan Linn., 
Korean J. Food Sci. Technol., 28(1), 77−82 
Mechetner, E., Kyshtoobayeva, A., Zonis, S., 
Kim, H., Stroup, R., Garcia, R., Parker, 
R.J. and Fruehauf, J.P., 1998, Levels of 
Multidrug Resistance (MDR1) P-
Glycoprotein Expression by Human 
Breast Cancer Correlate with in vitro 
Resistance to Taxol and Doxorubicin, 
Clin. Cancer Res., 4, 389-398. 
Reynolds, C.P. and Maurer, B.J., 2005, 
Evaluating Response to Antineoplastic 
Drug Combinations in Tissue Culture 
Models, Methods in Molecular Medicine, 
110, 173-183. 
Ueda, J.Y., Tezuka, Y., Banskota, A.H., Tran, 
Q.L., Tran, Q.K., Harimaya, Y., Saiki, I, 
and Kadota, S., 2002, Antiproliferative 
Activity of Vietnamese Medicinal Plants, 
Biol. Pharm. Bull, 25(6), 753-760. 
Wattanapitayakul, S.K., Chularojmontri, L., 
Herunsalee, A., Charuchongkolwongse, 
S., Niumsakul, S. and Bauer, J.A., 2005, 
Screening of Antioxidants from 
Medicinal Plants for Cardioprotective 
Effect against Doxorubicin Toxicity, 
Basic and Clin. Pharmacol. and Toxicol., 
96(1), 80-87. 
Yen, C., Nakagawa-Goto, K., Hwang, T.-L., 
Wu, P.-C., Morris-Natschke, S.L., Lai, 
W.-C., Bastow, K.F., Changb, F.-R., Wu, 
Y.-C. and Lee, K.-H., 2010, Antitumor 
Agents. 271. Total Synthesis and 
Evaluation of Brazilein and Analogs as 
Anti-inflammatory and Cytotoxic 
Agents, Bioorg Med Chem Lett, 20(3), 
1037–1039. 
Zhong, X., Wu, B., Pan, Y.J. and Zheng, S., 
2009, Brazilein Inhibits Survivin Protein 
and mRNA Expression and Induces 
Apoptosis in Hepatocellular Carcinoma 
HepG2 Cells, Neoplasma, 56(5). 
 
